Relationship Between Body Weight and Pharmacokinetics of Apixaban in Patients With Atrial Fibrillation: Insights from the ARISTOTLE Trial

被引：0
|
作者：
Harrington, Josephine
Giczewska, Anna
Wojdyla, Daniel
Washam, Jeffrey B.
Fudim, Marat
Hijazi, Ziad
Lopes, Renato D.
Hylek, Elaine
Hohnloser, Stefan H.
Goto, Shinya
Bahit, Maria
Wallentin, Lars C.
Granger, Christopher B.
Alexander, John H.
机构：
来源：
CIRCULATION | 2021年 / 144卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A9290
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight Insights From the ARISTOTLE Trial
    Hohnloser, Stefan H.
    Fudim, Marat
    Alexander, John H.
    Wojdyla, Daniel M.
    Ezekowitz, Justin A.
    Hanna, Michael
    Atar, Dan
    Hijazi, Ziad
    Cecilia Bahit, M.
    Al-Khatib, Sana M.
    Luis Lopez-Sendon, Jose
    Wallentin, Lars
    Granger, Christopher B.
    Lopes, Renato D.
    [J]. CIRCULATION, 2019, 139 (20) : 2292 - 2300
  • [2] Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial
    Cecilia Bahit, Maria
    Lopes, Renato D.
    Wojdyla, Daniel M.
    Hohnloser, Stefan H.
    Alexander, John H.
    Lewis, Basil S.
    Aylward, Philip E.
    Verheugt, Freek W. A.
    Keltai, Matyas
    Diaz, Rafael
    Hanna, Michael
    Granger, Christopher B.
    Wallentin, Lars
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 170 (02) : 215 - 220
  • [3] Apixaban in Patients with Atrial Fibrillation and Prior Coronary Artery Disease: Insights from the ARISTOTLE Trial
    Cecilia Bahit, Maria
    Lopes, Renato D.
    Hohnloser, Stephan H.
    Wojdyla, Daniel
    Alexander, John H.
    Lewis, Basil S.
    Aylward, Philip
    Verheugt, Freek W.
    Keltai, Matyas
    Diaz, Rafael
    Mohan, Puneet
    Granger, Christopher B.
    Wallentin, Lars
    [J]. CIRCULATION, 2012, 126 (21)
  • [4] Polypharmacy and the Impact of Apixaban on Clinical Events in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
    Focks, Jeroen Jaspers
    Brouwer, Marc A.
    Wojdyla, Daniel M.
    Tomas, Laine
    Lopes, Renato D.
    Hanna, Michael
    Lanas, Fernando
    Xavier, Denis
    Husted, Steen
    Wallentin, Lars
    Alexander, John H.
    Granger, Christopher B.
    Verheugt, Freek W.
    [J]. CIRCULATION, 2015, 132
  • [5] APIXABAN VERSUS WARFARIN FOR PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE TRIAL
    Guimaraes, Patricia
    Alexander, John
    Wojdyla, Daniel
    Thomas, Laine
    Alings, Marco
    Flaker, Greg
    Al-Khatib, Sana
    Hanna, Michael
    Wallentin, Lars
    Granger, Christopher
    Lopes, Renato
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 691 - 691
  • [6] Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy Insights From the ARISTOTLE Trial
    Al-Khatib, Sana M.
    Mulder, Hillary
    Wojdyla, Daniel
    Lopes, Renato D.
    Wallentin, Lars
    Alexander, John H.
    Hijazi, Ziad
    Goto, Shinya
    Granger, Christopher B.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2021, 14 (03): : 359 - 361
  • [7] Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
    Alexander, John H.
    Lopes, Renato D.
    Thomas, Laine
    Alings, Marco
    Atar, Dan
    Aylward, Philip
    Goto, Shinya
    Hanna, Michael
    Huber, Kurt
    Husted, Steen
    Lewis, Basil S.
    McMurray, John J. V.
    Pais, Prem
    Pouleur, Hubert
    Steg, Philippe Gabriel
    Verheugt, Freek W. A.
    Wojdyla, Daniel M.
    Granger, Christopher B.
    Wallentin, Lars
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (04) : 224 - 232
  • [8] Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
    Garcia, David A.
    Fisher, Deborah A.
    Mulder, Hillary
    Wruck, Lisa
    De Caterina, Raffele
    Halvorsen, Sigrun
    Granger, Christopher B.
    Held, Claes
    Wallentin, Lars
    Alexander, John H.
    Lopes, Renato D.
    [J]. AMERICAN HEART JOURNAL, 2020, 221 : 1 - 8
  • [9] THE EFFICACY AND SAFETY OF APIXABAN VERSUS WARFARIN ARE PRESERVED IN PATIENTS WITH ATRIAL FIBRILLATION AND EXTREMELY HIGH BODY WEIGHT: INSIGHTS FROM THE ARISTOTLE STUDY
    Fudim, Marat
    Lopes, Renato
    Alexander, John
    Wojdyla, Daniel
    Ezekowitz, Justin
    Hanna, Michael
    Atar, Dan
    Hijazi, Ziad
    Bahit, Maria
    Lopez-Sendon, Jose
    Wallentin, Lars
    Granger, Christopher
    Hohnloser, Stefan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 295 - 295
  • [10] Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
    Alexander, Karen P.
    Brouwer, Marc A.
    Mulder, Hillary
    Vinereanu, Dragos
    Lopes, Renato D.
    Proietti, Marco
    Al-Khatib, Sana M.
    Hijazi, Ziad
    Halvorsen, Sigrun
    Hylek, Elaine M.
    Verheugt, Freek W. A.
    Alexander, John H.
    Wallentin, Lars
    Granger, Christopher B.
    [J]. AMERICAN HEART JOURNAL, 2019, 208 : 123 - 131
12345